Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Expect a Hot, Smoky Summer in Much of America
The only break much of America can hope for anytime soon from eye-watering dangerous smoke from fire-struck Canada is brief bouts of shirt-soaking sweltering heat and humidity from a southern heat wave that has already proven deadly, forecasters say.
Load More